NeuroMetrix Announces Updates to Quell 2.0 Commercial Strategy
15 oct. 2019 11h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company that develops and commercializes products for the chronic pain and diabetes markets,...
NeuroMetrix, Inc. Announces Date for Third Quarter 2019 Financial Results Conference Call
10 oct. 2019 11h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Oct. 10, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 third quarter financial results before the opening of the market on...
NeuroMetrix Reports Q2 2019 Financial Results
18 juil. 2019 07h00 HE
|
NeuroMetrix, Inc.
WALTHAM, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2019. The Company develops and...
NeuroMetrix, Inc. Announces Date for Second Quarter 2019 Financial Results Conference Call
11 juil. 2019 13h15 HE
|
NeuroMetrix, Inc.
WALTHAM, Mass., July 11, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 second quarter financial results before the opening of the market on...
NeuroMetrix Provides Strategic Update
27 juin 2019 07h00 HE
|
NeuroMetrix, Inc.
WALTHAM, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company addressing chronic health conditions including chronic pain, sleep disorders and...
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
21 mai 2019 13h00 HE
|
NeuroMetrix, Inc.
WALTHAM, Mass., May 21, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,293,159 titled “Measuring the...
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
07 mai 2019 13h00 HE
|
NeuroMetrix, Inc.
WALTHAM, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,279,179 titled...
NeuroMetrix Reports Q1 2019 Financial Results
25 avr. 2019 07h00 HE
|
NeuroMetrix, Inc.
WALTHAM, Mass., April 25, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business highlights for the quarter ended March 31, 2019. The Company develops and...
NeuroMetrix, Inc. Announces Date for First Quarter 2019 Financial Results Conference Call
17 avr. 2019 11h00 HE
|
NeuroMetrix, Inc.
WALTHAM, Mass., April 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 first quarter financial results before the opening of the market...
NeuroMetrix Reports New Clinical Studies Published on DPNCheck
29 janv. 2019 13h00 HE
|
NeuroMetrix, Inc.
WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported publication of three new DPNCheck® clinical studies. DPNCheck is a point-of-care test that provides...